These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Heterozygous deletion of ATG5 in Apc(Min/+) mice promotes intestinal adenoma growth and enhances the antitumor efficacy of interferon-gamma. Wang L; Wang Y; Lu Y; Zhang Q; Qu X Cancer Biol Ther; 2015; 16(3):383-91. PubMed ID: 25695667 [TBL] [Abstract][Full Text] [Related]
23. A Tcf4-GFP reporter mouse model for monitoring effects of Apc mutations during intestinal tumorigenesis. Boman B; Kopelovich L; Siracusa LD; Zhang T; Henderson K; Cofer Z; Buchberg AM; Fields JZ; Otevrel T Mol Carcinog; 2009 Sep; 48(9):821-31. PubMed ID: 19263440 [TBL] [Abstract][Full Text] [Related]
24. A two-step model for colon adenoma initiation and progression caused by APC loss. Phelps RA; Chidester S; Dehghanizadeh S; Phelps J; Sandoval IT; Rai K; Broadbent T; Sarkar S; Burt RW; Jones DA Cell; 2009 May; 137(4):623-34. PubMed ID: 19450512 [TBL] [Abstract][Full Text] [Related]
25. Gastric Lgr5(+) stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice. Li XB; Yang G; Zhu L; Tang YL; Zhang C; Ju Z; Yang X; Teng Y Cell Res; 2016 Jul; 26(7):838-49. PubMed ID: 27091432 [TBL] [Abstract][Full Text] [Related]
26. Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β. Wiener Z; Band AM; Kallio P; Högström J; Hyvönen V; Kaijalainen S; Ritvos O; Haglund C; Kruuna O; Robine S; Louvard D; Ben-Neriah Y; Alitalo K Proc Natl Acad Sci U S A; 2014 May; 111(21):E2229-36. PubMed ID: 24825889 [TBL] [Abstract][Full Text] [Related]
27. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis. Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404 [TBL] [Abstract][Full Text] [Related]
28. Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: correlation with nuclear β-catenin. Femia AP; Dolara P; Salvadori M; Caderni G BMC Cancer; 2013 Feb; 13():48. PubMed ID: 23374535 [TBL] [Abstract][Full Text] [Related]
29. Tales from the human crypt--intestinal stem cell repertoire and the origins of human cancer. Playford RJ J Pathol; 1998 Jun; 185(2):119-22. PubMed ID: 9713336 [TBL] [Abstract][Full Text] [Related]
31. Suppression of intestinal tumors by targeting the mitotic spindle of intestinal stem cells. Yao R; Oyanagi J; Natsume Y; Kusama D; Kato Y; Nagayama S; Noda T Oncogene; 2016 Nov; 35(47):6109-6119. PubMed ID: 27157623 [TBL] [Abstract][Full Text] [Related]
32. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Faller WJ; Jackson TJ; Knight JR; Ridgway RA; Jamieson T; Karim SA; Jones C; Radulescu S; Huels DJ; Myant KB; Dudek KM; Casey HA; Scopelliti A; Cordero JB; Vidal M; Pende M; Ryazanov AG; Sonenberg N; Meyuhas O; Hall MN; Bushell M; Willis AE; Sansom OJ Nature; 2015 Jan; 517(7535):497-500. PubMed ID: 25383520 [TBL] [Abstract][Full Text] [Related]
33. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling. Nik AM; Reyahi A; Pontén F; Carlsson P Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422 [TBL] [Abstract][Full Text] [Related]
34. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. Haramis AP; Hurlstone A; van der Velden Y; Begthel H; van den Born M; Offerhaus GJ; Clevers HC EMBO Rep; 2006 Apr; 7(4):444-9. PubMed ID: 16439994 [TBL] [Abstract][Full Text] [Related]
35. The C-terminus of Apc does not influence intestinal adenoma development or progression. Lewis A; Davis H; Deheragoda M; Pollard P; Nye E; Jeffery R; Segditsas S; East P; Poulsom R; Stamp G; Wright N; Tomlinson I J Pathol; 2012 Jan; 226(1):73-83. PubMed ID: 22009253 [TBL] [Abstract][Full Text] [Related]
36. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression. Talla SB; Brembeck FH Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361 [TBL] [Abstract][Full Text] [Related]
39. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049 [TBL] [Abstract][Full Text] [Related]
40. Defining stem cell dynamics in models of intestinal tumor initiation. Vermeulen L; Morrissey E; van der Heijden M; Nicholson AM; Sottoriva A; Buczacki S; Kemp R; Tavaré S; Winton DJ Science; 2013 Nov; 342(6161):995-8. PubMed ID: 24264992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]